BIO is a curation and liquidity protocol for Decentralized Science (DeSci). Our mission is to accelerate biotechnology by giving global communities of patients, scientists and biotech professionals the ability to collectively fund, build and own tokenized biotech projects and intellectual property (IP).
The team behind BIO helped create Molecule, a tokenization platform for early-stage biomedicine, and VitaDAO, the largest decentralized community for longevity science. Building on these successes, BIO is designed to catalyze an onchain scientific economy through decentralized funding, incentives and liquidity.
The BIO token gives holders access to BIO's network of scientific communities and IP, enabling broad exposure to the DeSci economy.
Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for BIO. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: BIO is a Buy candidate.
BIO price ended at $0.029930 on 月曜日, after rising 11.42%
On Apr 20, 2026 00:00, the price of BIO rose by 11.42%, climbing from $0.032771 to $0.029930 with 24h trading volume reaching $91.7M BIO.
